Peptide Vaccination in Treating Patients With Esophageal Cancer

Clinical Trial ID NCT00682227

Rank	Title	Journal	Year	PubWeight™‹?›
1	Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer.	Cancer Sci	2009	1.49
2	Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes.	Cancer Res	2002	1.46
3	Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas.	Oncogene	2002	1.42
4	Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas.	Cancer Res	2007	1.42
5	Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy.	Cancer Sci	2007	1.35
6	Trial watch: Peptide vaccines in cancer therapy.	Oncoimmunology	2012	1.17